These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21319452)

  • 1. Triglycerides & omega-3s. Prescription omega-3 fatty acids are now among the hypertriglyceridemia therapies.
    Park NH
    Adv NPs PAs; 2010 Dec; 1(4):36-40. PubMed ID: 21319452
    [No Abstract]   [Full Text] [Related]  

  • 2. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
    Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM
    Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides.
    Sadovsky R; Kris-Etherton P
    Postgrad Med; 2009 Jul; 121(4):145-53. PubMed ID: 19641280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.
    Kim CH; Han KA; Yu J; Lee SH; Jeon HK; Kim SH; Kim SY; Han KH; Won K; Kim DB; Lee KJ; Min K; Byun DW; Lim SW; Ahn CW; Kim S; Hong YJ; Sung J; Hur SH; Hong SJ; Lim HS; Park IB; Kim IJ; Lee H; Kim HS
    Clin Ther; 2018 Jan; 40(1):83-94. PubMed ID: 29223557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omacor effects on serum lipids and clinical outcome.
    Ito MK; Marrs J; Williams C
    Am J Cardiol; 2007 Jan; 99(1):145. PubMed ID: 17196478
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
    Bays H
    Am J Cardiol; 2006 Aug; 98(4A):71i-76i. PubMed ID: 16919519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isosapent ethyl (Vascepa) for severe hypertriglyceridemia.
    Med Lett Drugs Ther; 2013 Apr; 55(1415):33-4. PubMed ID: 23836343
    [No Abstract]   [Full Text] [Related]  

  • 12. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients.
    Su TC; Hwang JJ; Huang KC; Chiang FT; Chien KL; Wang KY; Charng MJ; Tsai WC; Lin LY; Vige R; Olivar JE; Tseng CD
    J Atheroscler Thromb; 2017 Mar; 24(3):275-289. PubMed ID: 27600795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
    Davidson MH; Phillips AK; Kling D; Maki KC
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1045-54. PubMed ID: 25089906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription omega-3s: an overview for nurse practitioners.
    Mason CM; Long J; Conroy C
    J Cardiovasc Nurs; 2011; 26(4):290-7. PubMed ID: 21666421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids significantly reduce postprandial triglyceridemia in male smokers: a pilot study.
    Rein P; Saely CH; Aczel S; Patsch B; Drexel H
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):e3-4. PubMed ID: 19073364
    [No Abstract]   [Full Text] [Related]  

  • 16. Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy.
    Kataoka Y; Uno K; Puri R; Nicholls SJ
    Future Cardiol; 2013 Mar; 9(2):177-86. PubMed ID: 23463969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-chain omega-3 fatty acids: highly concentrated only as ethyl ester].
    MMW Fortschr Med; 2005 Oct; 147(43):61. PubMed ID: 16302427
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of prescription omega-3 fatty acid products for hypertriglyceridemia.
    Weintraub HS
    Postgrad Med; 2014 Nov; 126(7):7-18. PubMed ID: 25387209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study.
    Tatsuno I; Saito Y; Kudou K; Ootake J
    J Clin Lipidol; 2013; 7(6):615-25. PubMed ID: 24314359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ω-3 carboxylic acids for hypertriglyceridemia.
    Roth EM
    Expert Opin Pharmacother; 2015 Jan; 16(1):123-33. PubMed ID: 25480558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.